Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0950
-0.0050 (-5.00%)
At close: Mar 6, 2026
Altamira Therapeutics Employees
Altamira Therapeutics had 11 employees as of December 31, 2024. The number of employees increased by 1 or 8.65% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
8.65%
Revenue / Employee
n/a
Profits / Employee
-$513,903
Market Cap
542.97K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Avenue Therapeutics | 2 |
| Bio-Path Holdings | 10 |
| Windtree Therapeutics | 14 |
| Hepion Pharmaceuticals | 22 |
| Lipella Pharmaceuticals | 7 |
| Scorpius Holdings | 91 |
Altamira Therapeutics News
- 1 year ago - Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets - GlobeNewsWire
- 1 year ago - Altamira Therapeutics Provides Update on Nasdaq Listing - GlobeNewsWire
- 1 year ago - Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray - GlobeNewsWire
- 1 year ago - Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results - GlobeNewsWire
- 1 year ago - Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024 - GlobeNewsWire
- 1 year ago - Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering - GlobeNewsWire
- 1 year ago - Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering - GlobeNewsWire